UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...
Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...
COLORADO SPRINGS, Colo. (KRDO) -- September is prostate cancer awareness month, a time to focus on one of the most common cancers affecting men. The American Cancer Society estimates more than 300,00 ...
The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.
Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...
When prostate cancer has spread beyond the prostate to nearby lymph nodes and other areas of the body and treatments can no longer slow or stop its growth, you are not alone. Many patients, despite ...
Hosted on MSN
Prostate Cancer Can Now Be Detected Through These Identifiers In A Non-Invasive Urine Test
A silent killer that is the second leading cause of death among American men, prostate cancer is a disease that has recently come to the forefront of medical research. Studies and new reviews are ...
Among US men with grade group 1 (GG1) prostate cancer, about 1 in 6 had intermediate- or high-risk disease, along with increased rates of adverse pathology and cancer-specific mortality. This finding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results